COMPASS Pathways and Kings College London publish cognition results from COMP360...

Psychedelics: A New Fountain of Youth?

MEC Announces Submission of Listing Statement to the CSE in Coordination...

The Psilocybin vs. Escitalopram Trial – Part 2

Psychedelics and Cannabis ETF Launches on NYSE Arca in First for...

Cybin Announces Sponsorship of a Kernel Flow Feasibility Study to Measure...

Small Pharma Inc. Expands Phase I/IIa Clinical Trial With Additional Study...

PharmaTher and TSRL Enter into Co-Development Agreement For Microneedle Patch Delivery...

PT246 – Amber and Marcus Capone of VETS – Foundational Healing...

MYND Life Sciences announces Depression Biomarker Diagnostic Program

Load more